Innocrin Pharmaceuticals Overview
- Founded
-
2014

- Status
-
Out of Business
- Employees
-
10

- Latest Deal Type
-
Out of Business
Innocrin Pharmaceuticals General Information
Description
Developer of oral inhibitors designed to treat breast and prostate cancer. The company's inhibitors help in treating castration-resistant prostate cancer and are used in other hormonally-driven conditions such as endometriosis or congenital adrenal hyperplasia, thereby enabling hospitals to treat even non-oncologic syndromes caused due to excessive androgen production.
Contact Information
Website
www.innocrinpharma.org
Formerly Known As
Hephestics, Viamet Pharmaceuticals
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Medical Supplies
Therapeutic Devices
Drug Delivery
Primary Office
- 4220 Appex Highway 55
- Suite 330
- Durham, NC 27713
- United States
+1 (919) 000-0000
Innocrin Pharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Out of Business | 01-Oct-2019 | 000.00 | Completed | Out of Business | ||
3. Later Stage VC | 13-Jul-2017 | 000 | 000.00 | Completed | Generating Revenue | |
2. Later Stage VC | 20-Apr-2015 | $28.1M | $28.1M | Completed | Generating Revenue | |
1. Accelerator/Incubator | Completed | Startup |
Innocrin Pharmaceuticals Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of oral inhibitors designed to treat breast and prostate cancer. The company's inhibitors help in treating cas
Drug Discovery
Durham, NC
10
As of 2016
000.00
00000000 00
000.00
Innocrin Pharmaceuticals Competitors (15)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Aerami Therapeutics | Private Equity-Backed | Deerfield, IL | 00 | 00000 | 0000000 0000 | 00000 |
00000000 | Venture Capital-Backed | Middleton, WI | 00 | 000.00 | 0000000000 0 | 000.00 |
00000000 00000000 | Corporate Backed or Acquired | Cary, NC | 00 | 000000&0 | ||
0000000000 | Venture Capital-Backed | Pittsburgh, PA | 00 | 0000 | 00000000000 | 0000 |
0000 00000000000 | Formerly VC-backed | Cambridge, MA | 00 | 00000 | 00000000 | 00000 |
Innocrin Pharmaceuticals Patents
Innocrin Pharmaceuticals Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-2751117-A4 | Metalloenzyme inhibitor compounds | Inactive | 30-Aug-2011 | 0000000000 | |
EP-2751117-A2 | Metalloenzyme inhibitor compounds | Inactive | 30-Aug-2011 | 0000000000 | |
US-9150527-B2 | Metalloenzyme inhibitor compounds | Inactive | 30-Aug-2011 | 0000000000 | |
US-20140303157-A1 | Metalloenzyme inhibitor compounds | Active | 30-Aug-2011 | 0000000000 | |
AU-2012300275-A1 | Metalloenzyme inhibitor compounds | Inactive | 30-Aug-2011 | C07D277/24 |